Back
ADMA Biologics 10K Form
Buy
64
ADMA
ADMA Biologics
Last Price:
18.84
Seasonality Move:
6.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADMA News And Ratings
See the #1 stock for the next 7 days that we like better than ADMA
ADMA Financial Statistics
Sales & Book Value
| Annual Sales: | $258.22M |
|---|---|
| Cash Flow: | $43.28M |
| Price / Cash Flow: | 66.2 |
| Annual Sales: | $0.81 |
| Price / Book: | 23.31 |
Profitability
| EPS (TTM): | 0.14000 |
|---|---|
| Net Income (TTM): | $34.79M |
| Gross Margin: | $88.94M |
| Return on Equity: | 22.43% |
| Return on Assets: | 9.95% |
ADMA Biologics Earnings Forecast
Key ADMA Biologics Financial Ratios
- The Gross Profit Margin over the past 14 years for ADMA is 34.44%.
- The Selling, General & Administrative Expenses for ADMA have been equal to 22.86% of Gross Profit Margin.
- The Research & Development expenses have been 1.28% of Revenue.
- The Interest Expense is -88.63% of Operating Income.
- The Net Earning history of ADMA is -10.94% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 9 years.
ADMA Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADMA |
| CUSIP: | 000899 |
| Website: | admabiologics.com |
Debt
| Debt-to-Equity Ratio: | 0.7 |
|---|---|
| Current Ratio: | 6.87 |
| Quick Ratio: | 2.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 28.53 |
ADMA Technical Analysis vs Fundamental Analysis
Buy
64
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy or a Sell?
-
ADMA Biologics stock is rated a Buy
The current ADMA Biologics [ADMA] share price is $18.83. The Score for ADMA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.